Stem Cell Therapy Market worth 145.8 Million USD by 2021 - PowerPoint PPT Presentation

About This Presentation
Title:

Stem Cell Therapy Market worth 145.8 Million USD by 2021

Description:

The report "Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021 – PowerPoint PPT presentation

Number of Views:78

less

Transcript and Presenter's Notes

Title: Stem Cell Therapy Market worth 145.8 Million USD by 2021


1
MarketsandMarkets Presents
Stem Cell Therapy Market worth 145.8 Million
in 2021
2
  • The report Stem Cell Therapy Market by Treatment
    Mode (Autologous Allogeneic), Therapeutic
    Applications (CNS, CVS, GIT, Wound Healing,
    Musculoskeletal, Eye, Immune System) -
    Regulatory Landscape, Pipeline Analysis Global
    Forecasts to 2021 analyzes and studies the major
    market drivers, restraints, opportunities, and
    challenges in North America, Asia-Pacific,
    Europe, and the Rest of the World (RoW).
  • Browse 137 market data tables with 17 figures
    spread through 307 pages and in-depth TOC on
    Medical Power Supply Market by Technology (AC-DC
    DC-DC Power Supply), Type (External, Enclosed,
    Configurable, Encapsulated) Application (MRI,
    X-ray, CT, Ultrasound, EEG, ECG, Blood Pressure
    Monitor, Ventilator, PAP,VAD- Forecasts to 2017
  • http//www.marketsandmarkets.com/Market-Reports/st
    em-cell-technologies-and-global-market-48.html

3

4
  • This report studies the global stem cell therapy
    market over the forecast period of 2016 to
    2021.The market is poised to grow at a CAGR of
    11.0 from 2016 to 2021, to reach 145.8million
    by 2021.
  • The global stem cell therapy market on the basis
    of the mode of treatment is segmented into
    allogeneic and autologous stem cell therapy. In
    addition, based on the therapeutic applications,
    the global stem cell therapy market is segmented
    into eye diseases, metabolic diseases, GIT
    diseases, musculoskeletal disorders, immune
    system diseases, CNS diseases, CVS diseases,
    wounds and injuries, and others.

5
  • A number of factors such as the increasing
    funding from various government and private
    organizations, growing industry focus on stem
    cell research, and increasing global awareness
    about stem cell therapies through various
    organizations are stimulating the research
    activities for stem cell therapies. Developing
    markets, emergence of induced pluripotent stem
    (iPS) cells as an alternative to embryonic stem
    cells (ESCs), and evolution of new stem cell
    therapies represent high growth opportunities for
    market players.
  • In 2015, North America will hold the largest
    share of the global stem cell therapy market.
    This large share is primarily attributed to the
    extensive government funding and increasing
    fast-track approval for stem cell therapeutics by
    the FDA. Moreover, development of advanced
    genomic methods for stem cell analysis and high
    number of ongoing research activities are further
    fueling the growth of the stem cell therapy
    market in North America. However, the
    Asia-Pacific stem cell therapy market is expected
    to grow at the highest CAGR in the forecast
    period, owing to factors such as increasing
    regulatory support through favorable government
    policies, strong product pipelines, and
    increasing licensing activities in this region.

6
  • The stem cell therapy market includes large
    number of players that are involved in
    development of stem cell therapies of the
    treatment of various diseases. Mesoblast Ltd.
    (Australia), Aastrom Biosciences, Inc. (U.S.),
    Celgene Corporation (U.S.), and StemCells, Inc.
    (U.S.) are the key players involved in the
    development of stem cell therapies across the
    globe.

7
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
8
Contact Us
Mr. ShellyMarketsandMarkets701 Pike
Street,Suite 2175, Seattle,WA 98101, United
States1-888-600-6441Email sales_at_marketsandmarke
ts.com Visit MarketsandMarkets Blog _at_
http//mnmblog.org/market-research/healthcare/medi
cal-devices Connect with us on LinkedIn _at_
http//www.linkedin.com/company/marketsandmarkets
Write a Comment
User Comments (0)
About PowerShow.com